Search

Author/Creator Viada, C.

1. 536 RANIDO trial: Racotumomab-alum vaccine, Nimotuzumab or Docetaxel as switch maintenance therapy for advanced NSCLC. (September 2015)

Authors:
Hernandez, M.; Neninger, E.; Santiesteban, E.; Ortiz, R.; Amador, R.; Bello, L.; Acosta, S.; Flores, Y.; Cala, M.; Martínez, O.; Calana, A.; Pichs, G.; Robaina, M.; Sánchez, L.; Viada, C.; Valdez, A.; Mendoza, I.; Guerra, P.; Crombet, T.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S116
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. The anti‐CD6 antibody itolizumab provides clinical benefit without lymphopenia in rheumatoid arthritis patients: results from a 6‐month, open‐label Phase I clinical trial. (16th November 2017)

Authors:
Rodríguez, P. C.; Prada, D. M.; Moreno, E.; Aira, L. E.; Molinero, C.; López, A. M.; Gómez, J. A.; Hernández, I. M.; Martínez, J. P.; Reyes, Y.; Milera, J. M.; Hernández, M. V.; Torres, R.; Avila, Y.; Barrese, Y.; Viada, C.; Montero, E.; Hernández, P.
Journal:
Clinical and experimental immunology
Issue:
Volume 191:Number 2(2018:Feb.)
Page Start:
229
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. EGF-based vaccine: Recent immunological results in advanced lung cancer and non-invasive bladder cancer patients. (March 2019)

Authors:
Mazorra, Z.; Saavedra, D.; Popa, X.; Martínez, L.; Fuentes, K.; Huerta, V.; Alvarez, K.; Viada, C.; Neninger, E.; Ibañez, E.; Rodríguez, C.; Hernández, M.; González, Z.; González, A.; García, B.; Crombet, T.
Journal:
European journal of cancer
Issue:
Volume 110(2019)Supplement 1
Page Start:
S27
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗